Pavan Patel

Stock Analyst at B of A Securities

(0.25)
# 4,373
Out of 5,182 analysts
1
Total ratings
n/a
Success rate
-9.83%
Average return

Stocks Rated by Pavan Patel

Supernus Pharmaceuticals
Oct 29, 2025
Initiates: Buy
Price Target: $65
Current: $49.33
Upside: +31.77%